Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IQVIA Holdings, Inc. Common Stock (NY:IQV)

262.07 -6.78 (-2.52%)
Delayed Quote Updated: 2:43 PM EDT, Oct 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IQVIA Holdings, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
News headline image
IQVIA to Announce Third-Quarter 2026 Results on October 27, 2026
From IQVIA
Via Business Wire
IQVIA (NYSE:IQV) Nears Breakout With 10/10 Technical Strength and 9/10 Setup ↗
Via Chartmill
News headline image
IQVIA Announces Pricing of Senior Notes
From IQVIA Holdings Inc.
Via Business Wire
News headline image
IQVIA Announces Offering of Senior Notes
From IQVIA Holdings Inc.
Via Business Wire
News headline image
IQVIA (IQV): Buy, Sell, or Hold Post Q2 Earnings?
The past six months have been a windfall for IQVIA’s shareholders. The company’s stock price has jumped 50%, hitting $267.77 per share. This was partly thank... 
Via StockStory
News headline image
1 Profitable Stock with Solid Fundamentals and 2 That Underwhelm
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does... 
Via StockStory
News headline image
IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster
From IQVIA
Via Business Wire
News headline image
Q2 Earnings Roundup: IQVIA (NYSE:IQV) And The Rest Of The Drug Development Inputs & Services Segment
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services ind... 
Via StockStory
News headline image
IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare
From IQVIA
Via Business Wire
News headline image
2 Large-Cap Stocks with Exciting Potential and 1 That Underwhelm
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new are... 
Via StockStory
News headline image
IQVIA's AI-Enabled Clinical Decision Support Tool Wins 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year
From IQVIA
Via Business Wire
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
Thursday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
News headline image
IQVIA Ranked No. 1 Pharmaceutical Technology Provider by Everest Group
From IQVIA
Via Business Wire
News headline image
IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery
From IQVIA
Via Business Wire
News headline image
IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery
From Medera Inc.
Via GlobeNewswire
News headline image
5 Insightful Analyst Questions From IQVIA’s Q2 Earnings Call
IQVIA’s second quarter was characterized by broad-based growth and accelerating demand across its clinical and commercial businesses, with market participant... 
Via StockStory
Topics Artificial Intelligence Earnings
News headline image
1 Momentum Stock Worth Your Attention and 2 Facing Challenges
The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, pos... 
Via StockStory
News headline image
An IQVIA Insider Sold Just Before the Stock Slipped. Here's What Long-Term Investors Should Know ↗
This insider disposed of 16% of direct holdings at $245.21 per share, while maintaining nearly 3,000 shares valued at $740,000. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
An IQVIA Insider Just Sold Over $1 Million in Stock. Here's What Long-Term Investors Should Know ↗
Sherbet's disposition leaves him with 20,999 directly held shares valued at $5.2 million as IQVIA trades near $238. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
An IQVIA CEO Sold $26.1 Million as Bookings Hit a Record $3.15 Billion ↗
Bousbib exercised expiring stock appreciation rights while maintaining about 1.4 million shares in total beneficial ownership. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
1 Surging Stock with Exciting Potential and 2 Facing Challenges
The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, u... 
Via StockStory
Topics Energy
News headline image
IQV Q2 Deep Dive: Broad-Based Growth and AI-Driven Momentum Across Segments
Clinical research company IQVIA (NYSE: IQV) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 8.7% year on year to $4.37 billi... 
Via StockStory
Topics Artificial Intelligence
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
News headline image
IQVIA Q2 Earnings Call Highlights ↗
IQVIA (NYSE:IQV) reported second-quarter results that exceeded the high end of its guidance, supported by accelerating organic revenue growth, higher R&D Solutions bookings and operational productivity... 
Via MarketBeat
Topics Earnings
Curious about which S&P500 stocks are generating unusual volume on Tuesday? Find out below. ↗
Via Chartmill
Tuesday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
News headline image
IQVIA (IQV) Shares Skyrocket, What You Need To Know
What Happened? Shares of clinical research company IQVIA (NYSE: IQV) jumped 12.9% in the morning session after the company reported second-quarter results th... 
Via StockStory
Topics Artificial Intelligence
These S&P500 stocks are gapping in today's session ↗
Via Chartmill
These S&P500 stocks are moving in today's pre-market session ↗
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.